Diabetes tech companies are racing toward 'fully closed loop' devices. But automation comes with trade-offs.
Article excerpt
Highlighted: the sentence this signal was extracted from
Diabetes tech companies are racing toward 'fully closed loop' devices. But automation comes with trade-offs. Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management. Ahead of a prominent diabetes conference, several medical device companies are touting upcoming technologies they say will make it easier for people to manage their diabetes. Insulet, Tandem Diabetes Care and Medtronic spinoff MiniMed are all working on what they call fully closed loop automated insulin delivery, or AID, systems that use data from a glucose sensor to calculate how much insulin a person needs and then deliver it through an insulin pump. Unlike current AID systems on the market, these new systems would not require people to announce food or count carbohydrates ahead of mealtimes. Insulet plans to share late-breaking data at the American Diabetes Association's Scientific Sessions this weekend on the next phase of its feasibility study. MiniMed also will present a late-breaking poster session on development and clinical validation of its planned algorithm. The technology holds promise in reducing the burden of diabetes, experts said, but it does not automate everything. Device developers have to make decisions about how many options to give users and how to earn their trust. Medtech firms developing these systems are calling...
Keep reading with a free account
The rest of this article, and every signal for Insulet, is in your free account.
